| Systematic (IUPAC) name | |
|---|---|
| (6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-pentyl- 6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 36557-05-8 |
| ATC code | ? |
| PubChem | CID 37482 |
| ChemSpider | 34385 |
| Chemical data | |
| Formula | C21H30O3 |
| Mol. mass | 330.461 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
11-Hydroxy-Δ9-tetrahydrocannabinol, abbreviated as 11-OH-THC, is the main active metabolite of THC which is formed in the body after cannabis consumption.[1] 11-Hydroxy-THC has been shown to be active in its own right[2], but the effects produced are not necessarily identical to those of THC.[3][not in citation given (See discussion.)] This might partially explain the biphasic effects of cannabis, whereby some effects such as increased appetite tend to be delayed rather than occurring immediately when the drug is consumed.[4]
11-Hydroxy-THC is subsequently metabolised further to 11-nor-9-carboxy-THC, which is not psychoactive but might still play a role in the analgesic and anti-inflammatory effects of cannabis.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)